Literature DB >> 18300074

Identification of two small RNAs within the first 1.5-kb of the herpes simplex virus type 1-encoded latency-associated transcript.

Weiping Peng1, Olga Vitvitskaia, Dale Carpenter, Steven L Wechsler, Clinton Jones.   

Abstract

The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) is abundantly expressed in latently infected neurons. In the rabbit or mouse ocular models of infection, expression of the first 1.5 kb of LAT coding sequences is sufficient for and necessary for wild-type levels of spontaneous reactivation from latency. The antiapoptosis functions of LAT, which maps to the same 1.5 kb of LAT, are important for the latency-reactivation cycle because replacement of LAT with other antiapoptosis genes (the baculovirus IAP gene or the bovine herpesvirus type 1 latency-related gene) restores wild-type levels of reactivation to a LAT null mutant. A recent study identified a micro-RNA within LAT that can inhibit apoptosis (Gupta et al, Nature 442: 82-85). In this study, the authors analyzed the first 1.5 kb of LAT for additional small RNAs that may have regulatory functions. Two LAT-specific small RNAs were detected in productively infected human neuroblastoma cells within the first 1.5 kb of LAT, in a region that is important for inhibiting apoptosis. Although these small RNAs possess extensive secondary structure and a stem-loop structure, bands migrating near 23 bases were not detected suggesting these small RNAs are not true micro-RNAs. Both of the small LAT-specific RNAs have the potential to base pair with the ICP4 mRNA. These two small LAT RNAs may play a role in the latency-reactivation cycle by reducing apoptosis and/or by reducing ICP4 RNA expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300074     DOI: 10.1080/13550280701793957

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  91 in total

1.  Identification and characterization of human cytomegalovirus-encoded microRNAs.

Authors:  Finn Grey; Andy Antoniewicz; Edwards Allen; Julie Saugstad; Andy McShea; James C Carrington; Jay Nelson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Worms in L.A.

Authors:  Andrew Fraser
Journal:  Nat Genet       Date:  2003-09       Impact factor: 38.330

3.  Human cytomegalovirus expresses novel microRNAs during productive viral infection.

Authors:  Walter Dunn; Phong Trang; Qiu Zhong; Edward Yang; Christopher van Belle; Fenyong Liu
Journal:  Cell Microbiol       Date:  2005-11       Impact factor: 3.715

4.  Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes.

Authors:  J M Loutsch; G C Perng; J M Hill; X Zheng; M E Marquart; T M Block; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Authors:  Christopher S Sullivan; Adam T Grundhoff; Satvir Tevethia; James M Pipas; Don Ganem
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

6.  The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection.

Authors:  E K Wagner; W M Flanagan; G Devi-Rao; Y F Zhang; J M Hill; K P Anderson; J G Stevens
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript.

Authors:  Gail Henderson; Weiping Peng; Ling Jin; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

9.  Sendai virus trailer RNA binds TIAR, a cellular protein involved in virus-induced apoptosis.

Authors:  Frédéric Iseni; Dominique Garcin; Machiko Nishio; Nancy Kedersha; Paul Anderson; Daniel Kolakofsky
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

10.  Methods for detecting the HSV-1 LAT anti-apoptosis activity in virus infected tissue culture cells.

Authors:  Ling Jin; Guey-Chuen Perng; David J Brick; Julia Naito; Anthony B Nesburn; Clinton Jones; Steven L Wechsler
Journal:  J Virol Methods       Date:  2004-06-01       Impact factor: 2.014

View more
  27 in total

Review 1.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

2.  Antagonizing the Glucocorticoid Receptor Impairs Explant-Induced Reactivation in Mice Latently Infected with Herpes Simplex Virus 1.

Authors:  Kelly S Harrison; Liqian Zhu; Prasanth Thunuguntla; Clinton Jones
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

3.  The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

Review 4.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

5.  Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection.

Authors:  Afsar R Naqvi; Alexandra Seal; Jennifer Shango; Maria F Brambila; Gloria Martinez; Gabriela Chapa; Shirin Hasan; Tejabhiram Yadavalli; Dinesh Jaishankar; Deepak Shukla; Salvador Nares
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-03-15       Impact factor: 4.490

6.  A speculated ribozyme site in the herpes simplex virus type 1 latency-associated transcript gene is not essential for a wild-type reactivation phenotype.

Authors:  Dale Carpenter; Sukhpreet Singh; Nelson Osorio; Chinhui Hsiang; Xianzhi Jiang; Ling Jin; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

7.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15

8.  Identification of a novel herpes simplex virus type 1 transcript and protein (AL3) expressed during latency.

Authors:  Tareq Jaber; Gail Henderson; Sumin Li; Guey-Chuen Perng; Dale Carpenter; Steven L Wechsler; Clinton Jones
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

9.  Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis.

Authors:  Wenwen Shen; Mariana Sa e Silva; Tareq Jaber; Olga Vitvitskaia; Sumin Li; Gail Henderson; Clinton Jones
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  Small non-coding RNAs encoded within the herpes simplex virus type 1 latency associated transcript (LAT) cooperate with the retinoic acid inducible gene I (RIG-I) to induce beta-interferon promoter activity and promote cell survival.

Authors:  Leticia Frizzo da Silva; Clinton Jones
Journal:  Virus Res       Date:  2013-05-03       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.